Anti-DDAH2

Application

Research CategoryNeuroscience

Research Sub CategoryDevelopmental Signaling

Immunohistochemistry Analysis: A 1:500 dilution from a representative lot detected DDAH2 in human kidney and human cardiac myocytes tissue.

Detect Dimethylarginine dimethylaminohydrolase 2 using this rabbit polyclonal antibody, Anti-DDAH2 Antibody validated for use in western blotting & IHC (Paraffin).

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Dimethylarginine dimethylaminohydrolase 2 (DDAH2) is also called N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 (DDAH-2), DDAHII, Dimethylargininase-2, Protein G6a and S-phase protein. DDAH2 is involved in nitric oxide generation through the hydrolyzation of N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which are NOS inhibitors. DDAH2 is expressed in heart, placenta, lung, liver, skeletal muscle, kidney and pancreas.

Immunogen

Epitope: C-terminus

KLH-conjugated linear peptide corresponding to the C-terminus of human DDAH2.

Physical form

Affinity purified

Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Quality

Evaluated by Western Blotting in human heart tissue lysate.

Western Blotting Analysis: A 1:500 dilution of this antibody detected DDAH2 in 10 µg of human heart tissue lysate.

Storage and Stability

Stable for 1 year at 2-8°C from date of receipt.

Target description

~36 kDa observed. Uncharacterized band(s) may appear in some lysates.